CPHI News and Press, China Pharma Holdings Inc. From 08/15/19

China Pharma (NYSEMKT: CPHI ): Q2 GAAP EPS of -$0.02. More news on: China Pharma Holdings, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HAIKOU, China , Aug. 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China , today announced financial results for...

China Pharma Holdings, Inc. (CPHI) Q1 2019 Earnings Conference Call May 15, 2019 8:30 A.M. ET Company Participants Diana Huang - Investor Relations, Manager Zhilin Li - President and Chief Executive Officer and Interim Chief Financial Officer Sam Hsing - Corporate Vice President ...

China Pharma (NYSEMKT: CPHI ): Q1 GAAP EPS of -$0.01. More news on: China Pharma Holdings, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HAIKOU, China , May 15, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China , today announced financial results for ...

HAIKOU, China , May 7, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based in China , today announced that it plans to hold its first quarter 2019 earnings ...

China Pharma Holdings, Inc. (CPHI) Q4 2018 Results Conference Call March 29, 2019 08:00 AM ET Company Participants Diana Huang - IR, Manager Zhilin Li - President, CEO and Interim CFO Sam Hsing - Corporate Vice President Conference Call Participants Presentation Operat...

China Pharma (NYSEMKT: CPHI ): FY GAAP EPS of -$0.25. More news on: China Pharma Holdings, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

HAIKOU, China , March 29, 2019 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based in China , today announced financial results fo...